MeSH term
Frequency | Condition_Probility | Female | 16 | 0.0 |
Humans | 51 | 0.0 |
Middle Aged | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 55 | 0.0 |
Animals | 45 | 0.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Ear/*embryology | 2 | 50.0 |
Fibroblast Growth Factors/metabolism | 3 | 5.0 |
Homeodomain Proteins/*metabolism | 2 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 16 | 0.0 |
Trans-Activators/*metabolism | 3 | 0.0 |
Transcription Factors/*metabolism | 4 | 0.0 |
Adult | 4 | 0.0 |
Thyroglobulin/blood | 2 | 3.0 |
Thyrotropin/blood | 2 | 0.0 |
Amino Acid Sequence | 18 | 0.0 |
Base Sequence | 18 | 0.0 |
Child | 4 | 0.0 |
DNA Mutational Analysis | 3 | 0.0 |
Male | 13 | 0.0 |
Mice | 25 | 0.0 |
Mice, Knockout | 5 | 0.0 |
Molecular Sequence Data | 20 | 0.0 |
Mutation | 7 | 0.0 |
Phenotype | 7 | 0.0 |
Syndrome | 2 | 0.0 |
Thyroid Gland/*metabolism | 2 | 4.0 |
Infant, Newborn | 4 | 0.0 |
3T3 Cells | 3 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Cell Line | 11 | 0.0 |
DNA/genetics/metabolism | 2 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
*Nuclear Proteins | 30 | 1.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Transcription Factors/*genetics/physiology | 2 | 2.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Aged | 3 | 0.0 |
DNA-Binding Proteins/*genetics | 11 | 0.0 |
Nuclear Proteins/*genetics | 3 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Receptors, Cytoplasmic and Nuclear/*genetics | 2 | 2.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Trans-Activators/*genetics | 10 | 2.0 |
Transcription Factors/*genetics | 7 | 0.0 |
Gene Expression | 4 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Rats | 8 | 0.0 |
Child, Preschool | 2 | 0.0 |
*Mutation | 4 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Hela Cells | 7 | 0.0 |
Immunohistochemistry | 6 | 0.0 |
Kidney/*embryology | 4 | 13.0 |
Protein Structure, Tertiary | 3 | 0.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Trans-Activation (Genetics) | 5 | 0.0 |
COS Cells | 3 | 0.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
Genes, Reporter | 6 | 0.0 |
Transcription, Genetic/drug effects | 2 | 0.0 |
Transfection | 6 | 0.0 |
Alleles | 3 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Exons | 3 | 0.0 |
Models, Molecular | 3 | 0.0 |
Pedigree | 2 | 0.0 |
Promoter Regions (Genetics) | 6 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Transcription Factors/genetics | 3 | 0.0 |
Trans-Activators/*physiology | 2 | 0.0 |
Cell Differentiation | 6 | 0.0 |
DNA-Binding Proteins/biosynthesis | 2 | 2.0 |
In Situ Hybridization | 9 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Time Factors | 4 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Trans-Activators/biosynthesis | 2 | 5.0 |
Transcription Factors/biosynthesis | 2 | 2.0 |
Zebrafish | 2 | 1.0 |
DNA-Binding Proteins/*genetics/physiology | 2 | 2.0 |
Hypothyroidism/congenital/genetics | 2 | 50.0 |
Infant | 2 | 0.0 |
Thyroid Gland/*abnormalities | 3 | 60.0 |
Cell Division | 3 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 5 | 0.0 |
Nuclear Proteins/metabolism | 3 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Repressor Proteins/metabolism | 2 | 1.0 |
Thyroglobulin/genetics | 3 | 15.0 |
Trans-Activators/genetics/*metabolism | 4 | 1.0 |
Transcription Factors/metabolism | 4 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Models, Genetic | 3 | 0.0 |
Trans-Activators/metabolism | 4 | 0.0 |
Binding Sites | 4 | 0.0 |
Nuclear Proteins/genetics/metabolism | 5 | 2.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Thyrotropin/pharmacology | 2 | 3.0 |
Trans-Activators/genetics/metabolism | 5 | 2.0 |
Transcription Factors/genetics/metabolism | 6 | 1.0 |
Comparative Study | 7 | 0.0 |
*Gene Expression Regulation, Developmental | 4 | 0.0 |
Morphogenesis | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 3 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 4 | 0.0 |
Repressor Proteins/genetics/metabolism | 2 | 2.0 |
Chromosomes, Human, Pair 2/genetics | 2 | 1.0 |
Evolution, Molecular | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Interleukin-1/genetics | 2 | 2.0 |
DNA/metabolism | 4 | 0.0 |
Hypothyroidism/*congenital | 2 | 66.0 |
*Transcription, Genetic | 2 | 0.0 |
Cell Separation | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
RNA/metabolism | 2 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Chromosomes, Artificial, Yeast/genetics | 2 | 1.0 |
DNA Primers/genetics | 2 | 0.0 |
DNA-Binding Proteins/genetics | 4 | 0.0 |
Species Specificity | 2 | 0.0 |
Trans-Activators/genetics | 5 | 2.0 |
Adolescent | 2 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 3 | 0.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Nuclear Proteins/genetics | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Transcription, Genetic/genetics | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
Gene Expression Regulation, Developmental | 5 | 0.0 |
*Alternative Splicing | 2 | 0.0 |
Transcription, Genetic | 6 | 0.0 |
Biological Markers | 2 | 0.0 |
Karyotyping | 2 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 2 | 1.0 |
*Trans-Activation (Genetics) | 2 | 0.0 |
Trans-Activators/chemistry/genetics/*metabolism | 2 | 2.0 |
Chromosome Mapping | 3 | 0.0 |
Chromosomes, Human, Pair 2/*genetics | 2 | 1.0 |
*Genes, Wilms Tumor | 4 | 2.0 |
Mesoderm/cytology | 2 | 5.0 |
Transcription Factors/biosynthesis/genetics | 2 | 2.0 |
WT1 Proteins | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Nuclear Proteins/genetics/*metabolism | 2 | 0.0 |
Kidney Neoplasms/*genetics | 2 | 0.0 |
Nephroblastoma/*genetics | 3 | 2.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Gene Deletion | 3 | 0.0 |
Thyrotropin/metabolism | 2 | 3.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Receptors, Cytoplasmic and Nuclear/*metabolism | 2 | 1.0 |
Thyroid Neoplasms/*metabolism | 2 | 5.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |